Literature DB >> 20414029

[Histological complete response in a case of advanced gastric cancer treated by neo-adjuvant chemotherapy with S-1/CDDP].

Noriko Oshima1, Yutaka Tanizawa, Etsuro Bando, Taiichi Kawamura, Masanori Tokunaga, Norihiko Sugisawa, Yusuke Taki, Yoko Motegi, Narikazu Boku, Keiko Sasaki, Masanori Terashima.   

Abstract

A 59-year-old male was found to have advanced gastric cancer with multiple lymph node metastasis including para-aortic lymph nodes(cT3, cN3, cM0, cH0, cP0, cStage IV). Since curative surgery was deemed not feasible, we tried neoadjuvant chemotherapy expecting downstaging of the tumor. S-1(120 mg/body)was orally administered for three weeks followed by one week rest, and CDDP(60 mg/m2)was administered on day 8. Three courses of treatment resulted in a marked shrinkage of the primary lesion and a reduction of lymph nodes. He was judged as clinical PR by RECIST, and a radical resection was considered possible. Laparotomy revealed neither ascites nor peritoneal dissemination, and he underwent total gastrectomy, splenectomy and D2+para-aortic lymph node dissection with curative intent. The histological diagnosis revealed complete disappearance of cancer cells in the primary lesion of the stomach and lymph nodes, confirming a pathological complete response. The patient has been alive for six months without recurrence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414029

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Long-term survival of a patient with advanced gastric cancer with paraaortic lymph node metastasis who attained pathological complete response after S-1/CDDP chemotherapy: A case report.

Authors:  Yuta Ushida; Kiyoshi Hiramatsu; Satomi Saeki; Takeshi Amemiya; Hidenari Goto; Toshiyuki Arai
Journal:  Int J Surg Case Rep       Date:  2017-08-18

2.  Long-term survival results of patients with locally advanced gastric cancer and pathological complete response after neoadjuvant chemotherapy and resection.

Authors:  Tongbo Wang; Nianchang Wang; Hong Zhou; Aiping Zhou; Jing Jin; Yingtai Chen; Dongbing Zhao
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.